Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04890821 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System
A NA study of Tricuspid Regurgitation Functional, sponsored by Cardiac Implants.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT04890821: Recruiting NA study of Tricuspid Regurgitation Functional, sponsored by Cardiac Implants.
NCT04890821 is a NA study of Tricuspid Regurgitation Functional that is actively recruiting participants, run by Cardiac Implants. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04890821, a NA study of Tricuspid Regurgitation Functional, is actively recruiting participants, sponsored by Cardiac Implants.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
An early feasibility study to evaluate the safety and performance of 1) the transcatheter delivery and implantation of the Cardiac Implants (CI) annuloplasty ring and 2) the adjustment of the ring approximately 90 days following implantation in patients suffering from ≥ moderate functional tricuspid regurgitation (FTR).
Primary Outcome
Freedom from mortality determined to be primarily caused by the device or procedure in the primary endpoint cohort. Events adjudicated by a Clinical Events Committee (CEC).
Conditions Studied
Interventions
- DEVICE CI Percutaneous Ring Annuloplasty System
Study Locations (2)
New Jersey
- Hackensack University Medical Center - Hackensack
New York
- Weill Cornell Medicine-New York Presbyterian Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-12 |
| Est. Completion | 2027-09 |
| Phase | NA |
What NCT04890821 shows while recruiting
NCT04890821 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Tricuspid Regurgitation Functional appearing as the primary indexed condition, and to 1 intervention - of which CI Percutaneous Ring Annuloplasty System is the first listed.
NCT04890821 reports a single indexed study location in New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT04890821 about?
NCT04890821 is a clinical study titled "Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System". An early feasibility study to evaluate the safety and performance of 1) the transcatheter delivery and implantation of the Cardiac Implants (CI) annuloplasty ring and 2) the adjustment of the ring approximately 90 days following implantation in patients suffering from ≥ moderate functional tricuspid...
What is the current status of trial NCT04890821?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2021-12. Estimated completion is 2027-09.
What conditions does trial NCT04890821 study?
This clinical trial studies the following conditions: Tricuspid Regurgitation Functional.
What interventions are being tested in trial NCT04890821?
The interventions under investigation include: CI Percutaneous Ring Annuloplasty System (DEVICE).
Who is sponsoring clinical trial NCT04890821?
This trial is sponsored by Cardiac Implants, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04890821 being conducted?
This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Regurgitation Functional
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04890821's enrollment target sits among peer trials
15 1882nd of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia